363 related articles for article (PubMed ID: 1666609)
1. [The activity and properties of Na,K-ATPase in the erythrocytes and the Na-pump inhibitor in the plasma of subjects with borderline arterial hypertension].
Maslova MN; Ogorodnikova LE; Titkov IuS
Fiziol Zh SSSR Im I M Sechenova; 1991 Sep; 77(9):232-7. PubMed ID: 1666609
[TBL] [Abstract][Full Text] [Related]
2. Alteration of erythrocyte membrane Na, K-ATPase in children with borderline or essential hypertension.
Stojadinovic ND; Petronijević MR; Pavićević MH; Mrsulja BB; Kostić MM
Cell Biochem Funct; 1996 Jun; 14(2):79-87. PubMed ID: 8640956
[TBL] [Abstract][Full Text] [Related]
3. [Various properties of the Na+, K(+)-ATPase and the Mg (2+)-ATPase in erythrocytes from normotensive and hypertensive subjects].
Canestrari F; Galli F; Gheller G; De Crescentini S; Biagiarelli B
Boll Soc Ital Biol Sper; 1991 Jul; 67(7):659-66. PubMed ID: 1667978
[TBL] [Abstract][Full Text] [Related]
4. [Circulating inhibitor of the Na+-K+ pump in essential hypertension. Physiological and pharmacological variations].
Pernollet MG; de Thé H; Delva P; Wauquier I; Devynck MA; Baudouin-Legros M; Deray G; Rosenfeld J; Meyer P
Arch Mal Coeur Vaiss; 1984 Oct; 77(11):1283-7. PubMed ID: 6098238
[TBL] [Abstract][Full Text] [Related]
5. Plasma endogenous sodium pump inhibitor in essential hypertension.
Cloix JF; Devynck MA; Elghozi JL; Kamal LA; Lacerda-Jacomini LC; Meyer P; Pernollet MG; Rosenfeld JB; De Thé H
J Hypertens Suppl; 1983 Dec; 1(2):11-4. PubMed ID: 6100615
[TBL] [Abstract][Full Text] [Related]
6. [Alcohol-related high blood pressure, and erythrocyte Na+/K(+)-ATPase activity, sodium and potassium concentrations].
Tsuritani I; Teraoka K; Miyagoshi M; Honda R; Ishizaki M; Yamada Y
Rinsho Byori; 1993 Dec; 41(12):1353-7. PubMed ID: 8295347
[TBL] [Abstract][Full Text] [Related]
7. Reduction of erythrocyte (Na(+)-K+)ATPase activity in type 2 (non-insulin-dependent) diabetic patients with microalbuminuria.
Mimura M; Makino H; Kanatsuka A; Asai T; Yoshida S
Horm Metab Res; 1994 Jan; 26(1):33-8. PubMed ID: 8150421
[TBL] [Abstract][Full Text] [Related]
8. Abnormal erythrocyte Na, K-ATPase activity in a northeastern Thai population.
Tosukhowong P; Chotikasatit C; Tungsanga K; Sriboonlue P; Prasongwattana V; Pansin P; Sitprija V
Southeast Asian J Trop Med Public Health; 1992 Sep; 23(3):526-30. PubMed ID: 1336901
[TBL] [Abstract][Full Text] [Related]
9. [Na K ATPase activity in mammalian erythrocytes].
Kazennov AM; Maslova MN; Shalabodov AD
Biokhimiia; 1984 Jul; 49(7):1089-95. PubMed ID: 6089915
[TBL] [Abstract][Full Text] [Related]
10. Erythrocyte and plasma Ca2+, Mg2+ and cell membrane adenosine triphosphatase activity in patients with essential hypertension.
Fu Y; Wang S; Lu Z; Li H; Li S
Chin Med J (Engl); 1998 Feb; 111(2):147-9. PubMed ID: 10374376
[TBL] [Abstract][Full Text] [Related]
11. Clinical and biochemical approach of a circulating Na+-pump inhibitor.
Devynck MA; de The H; Pernollet MG; Cloix JF; Rosenfeld JB; Kamal LA; Meyer P
J Physiol (Paris); 1984; 79(6):538-41. PubMed ID: 6152634
[TBL] [Abstract][Full Text] [Related]
12. Erythrocyte membrane ouabain-sensitive Na+, K(+)-ATPase of hypertensive Nigerians.
Olorunsogo OO; Lawal SO; Falase AO; Okunade WG
Afr J Med Med Sci; 1991 Jun; 20(2):75-82. PubMed ID: 1652190
[TBL] [Abstract][Full Text] [Related]
13. [Incorporation of Na,K-ATPase into human erythrocyte membranes using liposomes].
Stel'makh LN; Rozhmanova OM; Lishko VK
Biokhimiia; 1984 Mar; 49(3):460-3. PubMed ID: 6326865
[TBL] [Abstract][Full Text] [Related]
14. Cellular mechanism relating sodium and potassium to hypertension.
Zhao GS; Li DY; Zhu DL; Kong DW; Qian YW; Li DP
Ann Clin Res; 1984; 16 Suppl 43():55-61. PubMed ID: 6100156
[TBL] [Abstract][Full Text] [Related]
15. Relation of erythrocyte Na+-K+ ATPase activity and cholesterol and oxidative stress in patients with type 2 diabetes mellitus.
Konukoglu D; Kemerli GD; Sabuncu T; Hatemi H
Clin Invest Med; 2003 Dec; 26(6):279-84. PubMed ID: 14690302
[TBL] [Abstract][Full Text] [Related]
16. Some properties of erythrocyte Na+-K+-ATPase in essential hypertension.
Kazennov AM; Maslova MN; Shalabodov AD; Bagrov JYu ; Gurevich VS
Clin Exp Hypertens A; 1987; 9(7):1221-32. PubMed ID: 3040305
[TBL] [Abstract][Full Text] [Related]
17. Copper modifies the activity of sodium-transporting systems in erythrocyte membrane in patients with essential hypertension.
Kedzierska K; Bober J; Ciechanowski K; Gołembiewska E; Kwiatkowska E; Noceń I; Dołegowska B; Dutkiewicz G; Chlubek D
Biol Trace Elem Res; 2005 Oct; 107(1):21-32. PubMed ID: 16170219
[TBL] [Abstract][Full Text] [Related]
18. Alteration in ouabain-sensitive sodium potassium pump of erythrocytes during pregnancy induced hypertension: a kinetic study.
Kaur G; Kapoor N; Mohan P; Sri Nageswari K; Singh MJ; Prasad R
J Biochem Mol Biol Biophys; 2002 Jun; 6(3):163-6. PubMed ID: 12186749
[TBL] [Abstract][Full Text] [Related]
19. [Presence and regulation of plasma with natriuretic and Na-K ATPase inhibitory properties in normotensive subjects].
Krzesinski JM; Potier JP; Godon JP; Rorive GL
Arch Mal Coeur Vaiss; 1987 Jun; 80(6):960-5. PubMed ID: 2821949
[TBL] [Abstract][Full Text] [Related]
20. Internal desynchronization between circadian rhythms of plasma aldosterone and erythrocyte membrane-bound Na/K-ATPase.
Cugini P; Letizia C; Murano G; Lucia P; Scavo D; Verna R
Prog Clin Biol Res; 1987; 227B():219-28. PubMed ID: 2819894
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
